ST Pharm breaks ground on 2nd State-of-the-Art Oligonucleotide Facility

Contributed by: PR Newswire

Tags

ST-Pharm-Co

More Like This

SK pharmteco Invests $260 Million to Expand Global Small Molecule and Peptide Production

TriLink BioTechnologies® Cuts Ribbon on New San Diego Facility for Late Phase mRNA Drug Substance Production (Photo: TriLink BioTechnologies®)

TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production

Olon is ready to host productions in the new facility dedicated to ultra-potent compounds

PR Newswire associated0

SK pharmteco to showcase its extensive APIs and CGT capabilities in CPHI 2023

PR Newswire associated0

LOTTE BIOLOGICS Holds Groundbreaking for Songdo Bio Campus

Asymchem’s Fully Automated Peptide Production Lines Set New Benchmarks as Large-Scale Capacity Continues to Grow

AGC Biologics Completes pDNA and mRNA Line Expansion in Heidelberg

BeiGene's flagship biologics manufacturing facility and clinical R&D center at the Princeton West Innovation Campus in Hopewell, N.J., is seen. (Photo: Business Wire)

BeiGene Opens Flagship U.S. Biologics Manufacturing and Clinical R&D Facility, Continues Global Expansion to Deliver Medicines to More Patients Around the World